AT541844T - Antiviral connections - Google Patents

Antiviral connections

Info

Publication number
AT541844T
AT541844T AT06848055T AT06848055T AT541844T AT 541844 T AT541844 T AT 541844T AT 06848055 T AT06848055 T AT 06848055T AT 06848055 T AT06848055 T AT 06848055T AT 541844 T AT541844 T AT 541844T
Authority
AT
Austria
Prior art keywords
antiviral
connections
Prior art date
Application number
AT06848055T
Other languages
German (de)
Inventor
David Betebenner
David DEGOEY
Clarence MARING
Allan KRUEGER
Nobuhiko Iwasaki
Todd ROCKWAY
Curt COOPER
David Anderson
Pamela DONNER
Brian Green
Dale Kempf
Dachun Liu
Keith F Mcdaniel
Darold Madigan
Christopher Motter
John PRATT
Jason Shanley
Michael Tufano
Rolf Wagner
Rong Zhang
Akhteruzzaman Molla
Hongmei Mo
Tami Pilot-Matias
Sherie Masse
Robert Carrick
Weping He
Liangjun Lu
David GRAMPOVNIK
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US75247305P priority Critical
Application filed by Abbott Lab filed Critical Abbott Lab
Priority to US11/613,810 priority patent/US7910595B2/en
Priority to PCT/US2006/049079 priority patent/WO2007076034A2/en
Publication of AT541844T publication Critical patent/AT541844T/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
AT06848055T 2005-12-21 2006-12-20 Antiviral connections AT541844T (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US75247305P true 2005-12-21 2005-12-21
US11/613,810 US7910595B2 (en) 2005-12-21 2006-12-20 Anti-viral compounds
PCT/US2006/049079 WO2007076034A2 (en) 2005-12-21 2006-12-20 Anti-viral compounds

Publications (1)

Publication Number Publication Date
AT541844T true AT541844T (en) 2012-02-15

Family

ID=38226308

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06848055T AT541844T (en) 2005-12-21 2006-12-20 Antiviral connections

Country Status (15)

Country Link
US (1) US7910595B2 (en)
EP (1) EP1979348B1 (en)
JP (1) JP2009521479A (en)
KR (1) KR20080080395A (en)
CN (1) CN102702193A (en)
AT (1) AT541844T (en)
AU (1) AU2006330924B2 (en)
CA (1) CA2633757A1 (en)
ES (1) ES2378473T3 (en)
HK (1) HK1122291A1 (en)
IL (1) IL192306D0 (en)
NZ (1) NZ569817A (en)
RU (1) RU2441869C2 (en)
WO (1) WO2007076034A2 (en)
ZA (1) ZA200805304B (en)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7915411B2 (en) 2005-12-21 2011-03-29 Abbott Laboratories Anti-viral compounds
WO2008133753A2 (en) * 2006-12-20 2008-11-06 Abbott Laboratories Anti-viral compounds
US7964580B2 (en) 2007-03-30 2011-06-21 Pharmasset, Inc. Nucleoside phosphoramidate prodrugs
ES2550755T3 (en) 2007-08-03 2015-11-12 Romark Laboratories, L.C. Thiazolide compounds substituted with alkylsulfonyl
AU2009267161B2 (en) * 2008-07-03 2014-11-06 Merck Patent Gmbh Naphthyridininones as Aurora kinase inhibitors
CA2728228A1 (en) 2008-07-14 2010-01-21 Gilead Sciences, Inc. Oxindolyl inhibitor compounds
EA019341B1 (en) 2008-12-23 2014-02-28 Джилид Фармассет, Ллс. Nucleoside phosphoramidates
RU2505539C2 (en) * 2008-12-23 2014-01-27 Эбботт Лэборетриз Antiviral compounds
RU2505540C2 (en) * 2008-12-23 2014-01-27 Эббви Инк. Antiviral compounds
EP2376515A1 (en) 2008-12-23 2011-10-19 Pharmasset, Inc. Synthesis of purine nucleosides
CA2748034A1 (en) 2008-12-23 2010-07-01 Pharmasset, Inc. Purified 2'-deoxy'2'-fluoro-2'-c-methyl-nucleoside-phosphoramidate prodrugs for the treatment of viral infections
EP2385938B1 (en) 2009-01-12 2015-03-04 Pfizer Limited Sulfonamide derivatives
TWI438200B (en) 2009-02-17 2014-05-21 Squibb Bristol Myers Co Hepatitis c virus inhibitors
US8394968B2 (en) 2009-02-17 2013-03-12 Bristol-Myers Squibb Company Hepatitis C virus inhibitors
TW201035088A (en) 2009-02-27 2010-10-01 Supergen Inc Cyclopentathiophene/cyclohexathiophene DNA methyltransferase inhibitors
EP2421845B1 (en) * 2009-03-25 2013-04-17 Abbott Laboratories Antiviral compounds and uses thereof
US8796466B2 (en) 2009-03-30 2014-08-05 Bristol-Myers Squibb Company Hepatitis C virus inhibitors
US8680139B2 (en) * 2009-04-01 2014-03-25 Progenra Anti-neoplastic compounds, compositions and methods
SG174518A1 (en) 2009-04-02 2011-10-28 Merck Patent Gmbh Autotaxin inhibitors
TW201038559A (en) 2009-04-09 2010-11-01 Squibb Bristol Myers Co Hepatitis C virus inhibitors
US8143414B2 (en) 2009-04-13 2012-03-27 Bristol-Myers Squibb Company Hepatitis C virus inhibitors
RU2541571C2 (en) * 2009-04-15 2015-02-20 Эббви Инк. Antiviral compounds
CA2940954A1 (en) 2009-05-12 2010-11-18 Romark Laboratories L.C. Haloalkyl heteroaryl benzamide compounds
TWI598358B (en) 2009-05-20 2017-09-11 基利法瑪席特有限責任公司 Nucleoside phosphoramidates
PL2609923T4 (en) 2010-03-31 2017-11-30 Gilead Pharmasset Llc Process for the crystallisation of (s)-isopropyl 2-(((s)-(perfluorophenoxy)(phenoxy)phosphoryl)amino)propanoate
US8618076B2 (en) 2009-05-20 2013-12-31 Gilead Pharmasset Llc Nucleoside phosphoramidates
US8138215B2 (en) 2009-05-29 2012-03-20 Bristol-Myers Squibb Company Hepatitis C virus inhibitors
US8211928B2 (en) 2009-05-29 2012-07-03 Bristol-Myers Squibb Company Hepatitis C virus inhibitors
US8258316B2 (en) 2009-06-08 2012-09-04 Gilead Sciences, Inc. Alkanoylamino benzamide aniline HDAC inhibitor compounds
MX2011013166A (en) 2009-06-08 2012-01-30 Gilead Sciences Inc Cycloalkylcarbamate benzamide aniline hdac inhibitor compounds.
AR077060A1 (en) * 2009-06-11 2011-07-27 Abbott Lab antiviral compounds
US9394279B2 (en) 2009-06-11 2016-07-19 Abbvie Inc. Anti-viral compounds
NZ605440A (en) 2010-06-10 2014-05-30 Abbvie Bahamas Ltd Solid compositions comprising an hcv inhibitor
US8937150B2 (en) 2009-06-11 2015-01-20 Abbvie Inc. Anti-viral compounds
US8716454B2 (en) 2009-06-11 2014-05-06 Abbvie Inc. Solid compositions
KR20180032689A (en) 2009-06-26 2018-03-30 로마크 레버러토리즈, 엘.씨. Compounds and methods for treating influenza
WO2011046991A2 (en) * 2009-10-15 2011-04-21 Gilead Connecticut, Inc. Certain substituted ureas as modulators of kinase activity
US20110269956A1 (en) 2009-11-11 2011-11-03 Bristol-Myers Squibb Company Hepatitis C Virus Inhibitors
US20110274648A1 (en) 2009-11-11 2011-11-10 Bristol-Myers Squibb Company Hepatitis C Virus Inhibitors
US20110281910A1 (en) 2009-11-12 2011-11-17 Bristol-Myers Squibb Company Hepatitis C Virus Inhibitors
US20110137633A1 (en) * 2009-12-03 2011-06-09 Abbott Laboratories Anti-viral compounds and methods of identifying the same
US8377980B2 (en) 2009-12-16 2013-02-19 Bristol-Myers Squibb Company Hepatitis C virus inhibitors
US8362020B2 (en) 2009-12-30 2013-01-29 Bristol-Myers Squibb Company Hepatitis C virus inhibitors
EP2552931B1 (en) 2010-03-31 2014-07-23 Gilead Pharmasset LLC Stereoselective synthesis of phosphorus containing actives
ES2532356T3 (en) 2010-07-09 2015-03-26 Pfizer Limited N-sulfonylbenzamides as voltage dependent sodium channel inhibitors
JP2013536241A (en) * 2010-08-24 2013-09-19 ブリガム・ヤング・ユニバーシティBrigham Young University Anti-metastatic compound
JP6069215B2 (en) 2010-11-30 2017-02-01 ギリアド ファーマセット エルエルシー Compound
US8552047B2 (en) 2011-02-07 2013-10-08 Bristol-Myers Squibb Company Hepatitis C virus inhibitors
US9546160B2 (en) 2011-05-12 2017-01-17 Bristol-Myers Squibb Company Hepatitis C virus inhibitors
US10201584B1 (en) 2011-05-17 2019-02-12 Abbvie Inc. Compositions and methods for treating HCV
ES2659216T3 (en) 2011-09-16 2018-03-14 Gilead Pharmasset Llc Methods for the treatment of HCV
US8889159B2 (en) 2011-11-29 2014-11-18 Gilead Pharmasset Llc Compositions and methods for treating hepatitis C virus
US9034832B2 (en) 2011-12-29 2015-05-19 Abbvie Inc. Solid compositions
US9326973B2 (en) 2012-01-13 2016-05-03 Bristol-Myers Squibb Company Hepatitis C virus inhibitors
GB201216017D0 (en) * 2012-09-07 2012-10-24 Cancer Rec Tech Ltd Inhibitor compounds
UA118256C2 (en) 2013-01-31 2018-12-26 Гіліад Фармассет Елелсі Combination formulation of two antiviral compounds
US9717712B2 (en) 2013-07-02 2017-08-01 Bristol-Myers Squibb Company Combinations comprising tricyclohexadecahexaene derivatives for use in the treatment of hepatitis C virus
US20150023913A1 (en) 2013-07-02 2015-01-22 Bristol-Myers Squibb Company Hepatitis C Virus Inhibitors
US9775831B2 (en) 2013-07-17 2017-10-03 Bristol-Myers Squibb Company Combinations comprising biphenyl derivatives for use in the treatment of HCV
US9663486B2 (en) 2013-10-14 2017-05-30 Eisai R&D Management Co., Ltd. Selectively substituted quinoline compounds
PE20160608A1 (en) 2013-10-14 2016-07-08 Eisai Randd Man Co Ltd Quinoline compounds selectively substituted
WO2015103490A1 (en) 2014-01-03 2015-07-09 Abbvie, Inc. Solid antiviral dosage forms
EP2924039A1 (en) 2014-03-27 2015-09-30 Universität Zürich 2-Amino-1-phenyl-pyrrolo[3,2-b]quinoxaline-3-carboxamide derivates
JP6219516B2 (en) 2014-06-27 2017-10-25 アグロカネショウ株式会社 Method for producing 2-amino-6-methylnicotinic acid
WO2016197027A1 (en) * 2015-06-04 2016-12-08 Kura Oncology, Inc. Methods and compositions for inhibiting the interaction of menin with mll proteins
RU2601309C1 (en) * 2015-07-21 2016-11-10 Государственное бюджетное образовательное учреждение высшего профессионального образования "Волгоградский государственный медицинский университет" Министерства здравоохранения Российской Федерации, ГБОУ ВПО ВолгГМУ МЗ РФ Improved method of producing acid chlorides of hydroxybenzoic acids
US10239875B2 (en) 2017-06-16 2019-03-26 King Saud University Naphthyridinyl hydrazine derivatives as potent peripheral analgesic agents

Family Cites Families (89)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB774094A (en) * 1953-01-02 1957-05-08 Wellcome Found Improvements in or relating to pyrimidine compounds
US3021332A (en) * 1954-01-04 1962-02-13 Burroughs Wellcome Co Pyrido (2, 3-d) pyrimidine compounds and method of making
DE3643456A1 (en) * 1986-12-19 1988-06-23 Bayer Ag Cyano-trichloro-pyrido-pyrimidine
ES2009217A6 (en) * 1987-07-07 1989-09-16 Guillermo Tene Lab Morrith S A 4-amino deriv. of methyl-thio pyrido-pyrimidine prepn.
GB8912336D0 (en) 1989-05-30 1989-07-12 Smithkline Beckman Intercredit Compounds
US5034393A (en) * 1989-07-27 1991-07-23 Dowelanco Fungicidal use of pyridopyrimidine, pteridine, pyrimidopyrimidine, pyrimidopyridazine, and pyrimido-1,2,4-triazine derivatives
GB9127252D0 (en) * 1991-12-23 1992-02-19 Boots Co Plc Therapeutic agents
GB9312891D0 (en) * 1993-06-22 1993-08-04 Boots Co Plc Therapeutic agents
US5654307A (en) * 1994-01-25 1997-08-05 Warner-Lambert Company Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
IL112249A (en) 1994-01-25 2001-11-25 Warner Lambert Co Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds
GB9510757D0 (en) 1994-09-19 1995-07-19 Wellcome Found Therapeuticaly active compounds
AT247469T (en) 1995-06-07 2003-09-15 Pfizer Heterocyclic fused pyrimidine derivatives
US6395733B1 (en) * 1995-06-07 2002-05-28 Pfizer Inc Heterocyclic ring-fused pyrimidine derivatives
US6037157A (en) * 1995-06-29 2000-03-14 Abbott Laboratories Method for improving pharmacokinetics
US6130217A (en) * 1995-09-20 2000-10-10 Pfizer Inc Compounds enhancing antitumor activity of other cytotoxic agents
AR004010A1 (en) * 1995-10-11 1998-09-30 Glaxo Group Ltd heterocyclic compounds
HU9801177A3 (en) * 1995-11-14 1998-11-30 Pharmacia & Upjohn Spa Tetrahydronaphthyl, indanyl and indolyl substituted pyrido[2,3-d]pyrimidine and purine derivatives, process for their preparation and pharmaceutical compositions containing them
AP9901435A0 (en) 1996-07-13 1999-03-31 Glaxo Group Ltd Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
HRP970371A2 (en) 1996-07-13 1998-08-31 Kathryn Jane Smith Heterocyclic compounds
FR2751330B1 (en) 1996-07-16 1998-10-30 Pernod Ricard Method DERIVED production of natural 1,3-diol and derivatives of the corresponding natural 1,3-dioxane
EA003188B1 (en) 1996-08-06 2003-02-27 Пфайзер Инк Substituted pyrido- or pyrimido- containing 6,6- or 6,7- bicyclic derivatives
TW477787B (en) 1996-08-27 2002-03-01 Pfizer Pyrido six-membered nitrogen-containing cyclic ring derivatives having corticotropin releasing factor antagonist activity and pharmaceutical composition containing same
CN1252054C (en) * 1996-09-25 2006-04-19 曾尼卡有限公司 Qinoline derivatives inhibiting effect of growth factors
DE19647413A1 (en) 1996-11-15 1998-05-20 Hoechst Schering Agrevo Gmbh Substituted nitrogen heterocycles, to processes for their preparation and their use as pesticides
DE19647317A1 (en) * 1996-11-15 1998-05-20 Hoechst Schering Agrevo Gmbh Substituted nitrogen heterocycles, to processes for their preparation and their use as pesticides
CA2272705C (en) * 1996-11-27 2003-03-18 Pfizer Inc. Fused bicyclic pyrimidine derivatives
JP2001520655A (en) * 1997-04-16 2001-10-30 アボツト・ラボラトリーズ 5,7-substituted 4-aminopyrido [2,3-d] its use as a pyrimidine compound and the adenosine kinase inhibitor
JP2002504558A (en) * 1998-02-25 2002-02-12 エモリー ユニバーシテイ 2'-fluoro nucleoside
CZ289425B6 (en) 1998-05-20 2002-01-16 Eli Lilly And Company Imidazo[1,2-a]pyridine compounds, their use and pharmaceutical preparation in which the compounds are comprised
US6323180B1 (en) * 1998-08-10 2001-11-27 Boehringer Ingelheim (Canada) Ltd Hepatitis C inhibitor tri-peptides
US6184226B1 (en) * 1998-08-28 2001-02-06 Scios Inc. Quinazoline derivatives as inhibitors of P-38 α
TW519541B (en) * 1999-01-27 2003-02-01 Pfizer Prod Inc Substituted bicyclic derivatives useful as anticancer agents
GB9906566D0 (en) * 1999-03-23 1999-05-19 Zeneca Ltd Chemical compounds
WO2001021206A1 (en) * 1999-09-17 2001-03-29 Suntory Limited PREVENTIVES OR REMEDIES FOR MYOCARDITIS, DILATED CARDIOMYOPATHY AND CARDIAC INSUFFICIENCY CONTAINING NF-λB INHIBITORS AS THE ACTIVE INGREDIENT
AU1071301A (en) 1999-11-01 2001-05-14 Eli Lilly And Company Pharmaceutical compounds
AU1262001A (en) 1999-11-04 2001-05-14 Biochem Pharma Inc. Method for the treatment or prevention of flaviviridae viral infection using nucleoside analogues
TR200103147T1 (en) 1999-12-27 2002-06-21 Japan Tobacco Inc. Fused ring compounds and their use as pharmaceuticals.
ITMI992711A1 (en) * 1999-12-27 2001-06-27 Novartis Ag organic compounds
WO2001057040A1 (en) 2000-02-03 2001-08-09 Abbott Laboratories 6,7-disubstituted-4-aminopyrido[2,3-d]pyrimidine compounds
AU3527801A (en) 2000-02-18 2001-08-27 Iaf Biochem Int Method for the treatment or prevention of flavivirus infections using nucleoside analogues
MY164523A (en) 2000-05-23 2017-12-29 Idenix (Cayman) Ltd Methods and compositions for treating hepatitis c virus
US6448281B1 (en) 2000-07-06 2002-09-10 Boehringer Ingelheim (Canada) Ltd. Viral polymerase inhibitors
US7622503B2 (en) * 2000-08-24 2009-11-24 University Of Tennessee Research Foundation Selective androgen receptor modulators and methods of use thereof
US6610677B2 (en) * 2000-09-15 2003-08-26 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
US20040110785A1 (en) * 2001-02-02 2004-06-10 Tao Wang Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
WO2002089731A2 (en) * 2001-05-03 2002-11-14 Stanford University Agents for treatment of hcv and methods of use
US20030187026A1 (en) * 2001-12-13 2003-10-02 Qun Li Kinase inhibitors
EP1465900B1 (en) * 2002-01-10 2008-05-14 Bayer HealthCare AG Rho-kinase inhibitors
EP1471910A2 (en) * 2002-01-17 2004-11-03 Neurogen Corporation Substituted quinazolin-4-ylamine analogues as modulators of capsaicin receptors
JP2003321472A (en) * 2002-02-26 2003-11-11 Takeda Chem Ind Ltd Grk inhibitor
US7037913B2 (en) * 2002-05-01 2006-05-02 Bristol-Myers Squibb Company Bicyclo 4.4.0 antiviral derivatives
EP1511738A4 (en) * 2002-05-17 2007-05-09 Scios Inc Treatment of fibroproliferative disorders using tgf-beta inhibitors
US7183302B2 (en) * 2002-08-12 2007-02-27 Bristol-Myers Squibb Company Iminothiazolidinones as inhibitors of HCV replication
DE60322920D1 (en) 2002-08-13 2008-09-25 Shionogi & Co Heterocyclic compounds with hiv integrate-inhibitor effect
AU2003291149A1 (en) 2002-11-22 2004-06-18 Scios, Inc. USE OF TFG-Beta INHIBITORSTO COUNTERACT PATHOLOGIC CHANGES IN THE LEVEL OR FUNCTION OF STEROID/THYROID RECEPTORS
KR20050084292A (en) * 2002-12-13 2005-08-26 뉴로젠 코포레이션 2-substituted quinazolin-4-ylamine analogues as capsaicin receptor modulator
WO2004065392A1 (en) 2003-01-24 2004-08-05 Smithkline Beecham Corporation Condensed pyridines and pyrimidines and their use as alk-5 receptor ligands
TW200508224A (en) * 2003-02-12 2005-03-01 Squibb Bristol Myers Co Cyclic derivatives as modulators of chemokine receptor activity
JP2006521398A (en) 2003-03-28 2006-09-21 サイオス・インコーポレーテツド Bicyclic pyrimidine inhibitors of TGFβ
WO2004106308A1 (en) * 2003-05-27 2004-12-09 Pfizer Products Inc. Quinazolines and pyrido [3,4-d] pyrimidines as receptor tyrosine kinase inhibitors
CA2531327A1 (en) * 2003-07-03 2005-01-13 Myriad Genetics, Inc. Compounds and therapeutical use thereof
TW200510373A (en) 2003-07-14 2005-03-16 Neurogen Corp Substituted quinolin-4-ylamine analogues
US7329664B2 (en) * 2003-07-16 2008-02-12 Neurogen Corporation Substituted (7-pyridyl-4-phenylamino-quinazolin-2-yl)-methanol analogues
US7378414B2 (en) * 2003-08-25 2008-05-27 Abbott Laboratories Anti-infective agents
CA2537883A1 (en) * 2003-09-09 2005-03-17 Neurogen Corporation Substituted bicyclic quinazolin-4-ylamine derivatives
WO2005032481A2 (en) * 2003-09-30 2005-04-14 Scios Inc. Quinazoline derivatives as medicaments
US20050075331A1 (en) * 2003-10-06 2005-04-07 Pratt John K. Anti-infective agents
EP1678149A2 (en) * 2003-10-31 2006-07-12 Neurogen Corporation 4-amino(aza)quinoline derivatives as capsaicin receptor agonists
GB0326168D0 (en) * 2003-11-10 2003-12-17 Arrow Therapeutics Ltd Chemical compounds
MY141220A (en) * 2003-11-17 2010-03-31 Astrazeneca Ab Pyrazole derivatives as inhibitors of receptor tyrosine kinases
GB0326963D0 (en) * 2003-11-19 2003-12-24 Glaxo Group Ltd Compounds
WO2005082865A1 (en) 2004-02-27 2005-09-09 Astellas Pharma Inc. Fused bicyclic pyrimidine derivative
CA2555867A1 (en) * 2004-03-04 2005-09-22 Neurogen Corporation Arylalkylamino-substituted quinazoline analogues
EP1748991A1 (en) 2004-04-28 2007-02-07 Arrow Therapeutics Limited Morpholinylanilinoquinazo- line derivatives for use as antiviral agents
JP2008505079A (en) 2004-06-30 2008-02-21 メルク エンド カムパニー インコーポレーテッドMerck & Company Incoporated Estrogen receptor modulator
JP5046942B2 (en) 2004-09-30 2012-10-10 テイボテク・フアーマシユーチカルズTibotec Pharmaceuticals HCV-inhibiting bicyclic pyrimidines
GB0421908D0 (en) 2004-10-01 2004-11-03 Angeletti P Ist Richerche Bio New uses
WO2006067614A2 (en) * 2004-12-23 2006-06-29 Pfizer Products Inc. Heteroaromatic derivatives useful as anticancer agents
WO2006071875A1 (en) * 2004-12-29 2006-07-06 Millennium Pharmaceuticals, Inc. Compounds useful as chemokine receptor antagonists
WO2006100310A1 (en) * 2005-03-25 2006-09-28 Tibotec Pharmaceuticals Ltd Heterobicylic inhibitors of hcv
WO2006105063A1 (en) * 2005-03-25 2006-10-05 Scios Inc. Heterobicylic inhibitors of tgfbeta
AR054122A1 (en) * 2005-05-12 2007-06-06 Tibotec Pharm Ltd Pyrido [2,3-d] pyrimides useful as HCV inhibitors, and methods for preparation thereof
AR056347A1 (en) 2005-05-12 2007-10-03 Tibotec Pharm Ltd Use of pteridine compounds for producing medicaments and pharmaceutical compositions
DE102005022977A1 (en) * 2005-05-19 2006-12-07 Merck Patent Gmbh Phenylchinazolinderivate
AU2005336552B2 (en) 2005-09-23 2010-09-16 Equispharm Co., Ltd 5,6-dimethylthieno(2,3-di) pyrimidine derivatives, the preparation method thereof and the pharmaceutical composition comprising the same for anti-virus
WO2007060404A1 (en) * 2005-11-22 2007-05-31 Kudos Pharmaceuticals Limited PYRIDO-,PYRAZO- AND PYRIMIDO-PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS
CN101331116A (en) * 2005-12-12 2008-12-24 健亚生物科技公司 N-(6-membered aromatic ring)-amido anti-viral compounds
US7763731B2 (en) * 2005-12-21 2010-07-27 Abbott Laboratories Anti-viral compounds
US7915411B2 (en) * 2005-12-21 2011-03-29 Abbott Laboratories Anti-viral compounds

Also Published As

Publication number Publication date
EP1979348A2 (en) 2008-10-15
HK1122291A1 (en) 2012-09-21
JP2009521479A (en) 2009-06-04
KR20080080395A (en) 2008-09-03
US7910595B2 (en) 2011-03-22
CN102702193A (en) 2012-10-03
CA2633757A1 (en) 2007-07-05
WO2007076034A2 (en) 2007-07-05
NZ569817A (en) 2011-10-28
ZA200805304B (en) 2012-01-25
RU2008129810A (en) 2010-01-27
US20070232627A1 (en) 2007-10-04
AU2006330924B2 (en) 2012-03-15
EP1979348B1 (en) 2012-01-18
IL192306D0 (en) 2008-12-29
WO2007076034A3 (en) 2007-10-04
ES2378473T3 (en) 2012-04-12
RU2441869C2 (en) 2012-02-10
AU2006330924A1 (en) 2007-07-05

Similar Documents

Publication Publication Date Title
DK1893196T3 (en) Diarylhydantoin connection
DK1928882T3 (en) (S) -N-methylnaltrexone
AT408603T (en) pyrazolylcarboxanilides
DE602006017614D1 (en) Anastomoseverbunddichtung
DE602005017262D1 (en) Handstaubsauger
DE602006007822D1 (en) nrate
AT523504T (en) 1-thio-D-GLUCITOLDERIVATE
DE502006008299D1 (en) Nickness lanzette
DE602006020094D1 (en) Ösennahtanker
DE602006015986D1 (en) Instant-messaging-installation-bzw. -serverprotokoll
AT552163T (en) Straddle-VEHICLE
AT527526T (en) Photonenzählvorrichtung
DE602006018394D1 (en) Hybridcopolymere
DE602006015785D1 (en) L-DIMENSION-scatterometry
AT539711T (en) Hüftpfannenpositionierung
AT433506T (en) NANO-thermoelectrics
DE602005020856D1 (en) Unterhose
DE602006005805D1 (en) Verwirbelungsanordnung
DE602006017807D1 (en) Oberflächeninjizierungsvorrichtung
DE602006007998D1 (en) Styrylsulfidfarbstoffe
DE602006006066D1 (en) ermodulgehäuse
AT477250T (en) Cyanoanthranilamidinsektizide
AT530519T (en) Cyclobutylaminderivate
AT444717T (en) Lasermikroporator
DE602006019876D1 (en) Schleifagglomeratpolierverfahren